Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Mustang Bio Inc.

    NASDAQ: MBIO · Real-Time Price · USD
    1.16
    -0.11 (-8.66%)
    At close: Jun 13, 2025, 3:59 PM
    1.13
    -2.59%
    Pre-market: Jun 16, 2025, 08:00 AM EDT

    Mustang Bio Statistics

    Share Statistics

    Mustang Bio has 4.38M shares outstanding. The number of shares has increased by -0.1% in one year.

    Shares Outstanding

    n/a
    		 4.38M

    Shares Change (YoY)

    n/a
    		 -0.1%

    Shares Change (QoQ)

    n/a
    		 -0.31%

    Owned by Institutions (%)

    n/a
    		 1.07%

    Shares Floating

    n/a
    		 3.69M

    Failed to Deliver (FTD) Shares

    n/a
    		 3,028

    FTD / Avg. Volume

    n/a
    		 0.76%

    Short Selling Information

    The latest short interest is 97.08K, so 2.22% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 97.08K

    Short % of Shares Out

    n/a
    		 2.22%

    Short % of Float

    n/a
    		 2.75%

    Short Ratio (days to cover)

    n/a
    		 1

    Valuation Ratios

    The PE ratio is -3.44 and the forward PE ratio is -0.01. Mustang Bio's PEG ratio is 0.06.

    PE Ratio

    n/a
    		 -3.44

    Forward PE

    n/a
    		 -0.01

    PS Ratio

    n/a
    		 0

    Forward PS

    n/a
    		 0.1

    PB Ratio

    n/a
    		 -14

    P/FCF Ratio

    n/a
    		 -4.75

    PEG Ratio

    n/a
    		 0.06
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Mustang Bio.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 0.68, with a Debt / Equity ratio of -0.23.

    Current Ratio

    n/a
    		 0.68

    Quick Ratio

    n/a
    		 0.68

    Debt / Equity

    n/a
    		 -0.23

    Debt / EBITDA

    n/a
    		 -0.05

    Debt / FCF

    n/a
    		 -0.08

    Interest Coverage

    n/a
    		 3249

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 n/a

    Profits Per Employee

    n/a
    		 $-2,625,333.33

    Employee Count

    n/a
    		 6

    Asset Turnover

    n/a
    		 0

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 n/a

    Effective Tax Rate

    n/a
    		 0%

    Stock Price Statistics

    The stock price has increased by -82.15% in the last 52 weeks. The beta is 2.25, so Mustang Bio's price volatility has been higher than the market average.

    Beta

    n/a
    		 2.25

    52-Week Price Change

    n/a
    		 -82.15%

    50-Day Moving Average

    n/a
    		 1.24

    200-Day Moving Average

    n/a
    		 6.56

    Relative Strength Index (RSI)

    n/a
    		 40.24

    Average Volume (20 Days)

    n/a
    		 398,207

    Income Statement

    Revenue

    n/a
    		 n/a

    Gross Profit

    n/a
    		 n/a

    Operating Income

    n/a
    		 -16.25M

    Net Income

    n/a
    		 -15.75M

    EBITDA

    n/a
    		 -16.25M

    EBIT

    n/a
    		 -15.76M

    Earnings Per Share (EPS)

    n/a
    		 -2.57
    Full Income Statement

    Balance Sheet

    The company has 6.84M in cash and 878K in debt, giving a net cash position of 5.96M.

    Cash & Cash Equivalents

    n/a
    		 6.84M

    Total Debt

    n/a
    		 878K

    Net Cash

    n/a
    		 5.96M

    Retained Earnings

    n/a
    		 -396.72M

    Total Assets

    n/a
    		 14.91M

    Working Capital

    n/a
    		 3.76M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -11.41M and capital expenditures 0, giving a free cash flow of -11.41M.

    Operating Cash Flow

    n/a
    		 -11.41M

    Capital Expenditures

    n/a
    		 n/a

    Free Cash Flow

    n/a
    		 -11.41M

    FCF Per Share

    n/a
    		 -1.86
    Full Cash Flow Statement

    Margins

    Gross Margin

    n/a
    		 n/a

    Operating Margin

    n/a
    		 n/a

    Pretax Margin

    n/a
    		 n/a

    Profit Margin

    n/a
    		 n/a

    EBITDA Margin

    n/a
    		 n/a

    EBIT Margin

    n/a
    		 n/a

    FCF Margin

    n/a
    		 n/a

    Dividends & Yields

    MBIO does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for MBIO is $100, which is 8520.7% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $100

    Price Target Difference

    n/a
    		 8520.7%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 1
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Stock Splits

    The last stock split was on Jan 16, 2025. It was a backward split with a ratio of 1:50.

    Last Split Date

    n/a
    		 Jan 16, 2025

    Split Type

    n/a
    		 backward

    Split Ratio

    n/a
    		 1:50

    Scores

    Altman Z-Score

    n/a
    		 -39.11

    Piotroski F-Score

    n/a
    		 2

    Add to Watchlist